There’s still time to submit an abstract to the 2022 ESLA European Congress of Speech and Language Therapy! We have extended our abstract submission deadline until 15/10/21 and would love to receive your abstracts.

Abstract Submission

By clicking on the link you are leaving  the ESLA Congress website and are entering the Congress administration site (Columbus | RAM Congress+Event) hosted by EventsAir..

Abstract Submission Guidelines

The following guidelines are provided to assist you in submitting your abstract. Please follow these instructions when completing the abstract form. Abstracts can only be submitted online.

Papers and posters submitted for presentation at the ESLA congress should not have been previously published as a complete paper in an international journal. New reports in the field of speech and language therapy are welcome for presentation, but reports previously published as an abstract or as a full paper in a national journal or presented previously at a national meeting are also permissible. Abstracts or papers and posters that report on scientific work, new clinical and practical developments and perspectives, but also case reports that demonstrate important insights for clinicians are eligible for acceptance. Contributions addressing the congress theme “New frontiers in speech and language therapy: advancing practice, research and education” are particularly welcome.

The abstract should be structured as follows:

  • Background
  • Aim / Objectives 
  • Methods
  • Results
  • Conclusions / take home message
  • Keywords

Abstracts must be a maximum of 300 words (not including presenter names and titles).

Review Process

All abstracts will be reviewed in a blinded fashion for their quality and relevance by the Scientific Committee. If an abstract is not accepted for oral presentation, it is possible that the authors may instead be invited to present their work as a poster.


The new deadline for receipt of abstracts is 15th October, 2021.

The corresponding author will be notified by email regarding the status of the abstract by December 31st, 2021.